Evidence map›Paper›PMID 42827164›Full record

ArticleEuropean archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery2026

Universal newborn hearing screening in Southwest Iran: coverage, risk factors, and outcomes in a large-scale population.

Arash Bayat, Nader Saki, Mojtaba Javadi, Soheila Nikakhlagh, Marzieh Amiri

Abstract read
PubMed Publisher
In one paragraph

Article in European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Arash BayatDepartment of Audiology, School of Rehabilitation Sciences, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.ORCID http://orcid.org/0000-0002-9393-2426
Nader SakiHearing Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.ORCID http://orcid.org/0000-0003-4564-6406
Mojtaba JavadiDepartment of Otorhinolaryngology, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Soheila NikakhlaghHearing Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.ORCID http://orcid.org/0000-0002-2902-0385
Marzieh AmiriDepartment of Audiology, School of Rehabilitation Sciences, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran. amirimarzieh384@gmail.com.ORCID http://orcid.org/0000-0001-8787-1260

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPermanent neonatal hearing loss can significantly impact language, cognitive, and social development. Universal newborn hearing screening (UNHS) facilitates early detection and intervention, yet coverage and follow-up remain inconsistent, especially in low- and middle-income regions. Southwestern Iran, with its large birth cohort and high prevalence of consanguinity, offers a unique opportunity to evaluate the performance of the UNHS program and its associated neonatal risk factors.

objectiveThe primary objective of this study was to assess the overall coverage and lost-to-follow-up rates of UNHS in Khuzestan Province, Iran. The secondary objective was to evaluate the impact of established neonatal risk factors on auditory outcomes.

methodsThis prospective population-based cohort study included all newborns screened in 29 referral centers in Khuzestan Province from 2019 to 2023. A two-stage screening protocol using transient evoked otoacoustic emissions (TEOAEs) and automated auditory brainstem response (AABR) was applied, with diagnostic audiology for infants referred from screening. Associations between neonatal risk factors and hearing loss were analyzed using odds ratios (ORs) with 95% confidence intervals (CIs).

resultsOut of 450,542 live births, 403,833 newborns (89.96%) underwent hearing screening. A total of 7,491 infants (1.85%) were referred for diagnostic assessment, and permanent hearing loss was confirmed in 986 cases, corresponding to a prevalence of 2.44 per 1,000 live births. The prevalence was markedly higher among NICU-admitted infants compared to well-baby nursery infants (11.6 vs. 1.05 per 1,000 live births). Sensorineural hearing loss accounted for 78.49% of cases, and 59.12% were bilateral. Overall, 71.39% of affected infants had at least one recognized neonatal risk factor. In multivariable analysis, prematurity (aOR = 4.39; 95% CI: 1.38-11.81), consanguinity (aOR = 4.14; 95% CI: 1.71-6.73), neonatal hyperbilirubinemia (aOR = 3.14; 95% CI: 1.79-4.60), and family history of hearing loss (aOR = 3.29; 95% CI: 1.25-6.44) were identified as significant independent predictors.

conclusionsUNHS in southwestern Iran achieves substantial coverage and effectively identifies infants with permanent hearing loss. Targeted follow-up for high-risk populations and early intervention are critical to optimize auditory, speech, and cognitive outcomes.

Indexed as

Hearing lossIranNeonatal hearing screeningRisk factors

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.